IGF-BP3 Recombinant Protein

SKU: orb1230937

Description

IGF-BP3 Recombinant Protein

Research Area

Cancer Biology, Cell Biology, Metabolism Research, Signal Transduction

Key Properties

• Source: E. coli
• Biological Activity: The ED50 was determined by its ability to inhibit IGF - II induced proliferation of MCF - 7. The expected ED50 for this effect is ≤ 0.2 μg/mL in presence of 15 ng/mL of human IGF - II.
• Target: IGFBP3
• Protein Sequence: GASSGGLGPV VRCEPCDARA LAQCAPPPAV CAELVREPGC GCCLTCALSE GQPCGIYTER CGSGLRCQPS PDEARPLQAL LDGRGLCVNA SAVSRLRAYL LPAPPAPGNA SESEEDRSAG SVESPSVSST HRVSDPKFHP LHSKIIIIKK GHAKDSQRYK VDYESQSTDT QNFSSESKRE TEYGPCRREM EDTLNHLKFL NVLSPRGVHI PNCDKKGFYK KKQCRPSKGR KRGFCWCVDK YGQPLPGYTT KGKEDVHCYS MQSK
• Purity: Greater than 98% by SDS-PAGE gel and HPLC analyses.Endotoxin level is less than 0.1 ng per μg (1EU/μg).

Storage & Handling

• Storage: The lyophilized IGF-BP3 recombinant protein is stable for at least 2 years from date of receipt at -20°C. Reconstituted IGF-BP3 is stable for at least 3 months when stored in working aliquots with a carrier protein at -20°C. As with any protein, exposing IGF-BP3 recombinant protein to repeated freeze / thaw cycles is not recommended. When working with proteins care should be taken to keep recombinant protein at a cool and stable temperature.
• Form/Appearance: Lyophilized
• Expiration Date: 6 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

IBP3, BP-53, IBP3, Insulin-like growth factor-binding protein 3, IBP-3

Quick Database Links

Gene Symbol

IGFBP3

UniProt

P17936

RefSeq (Protein):NP_000589.2